Earnings Forecast Research on Amarin Corporation plc (AMRN)

Amarin Corporation PLC has received $-0.09 as the consensus Earnings Estimate for the Quarter ending on Dec 2016 ,According to the estimate provided by 2 Financial Advisor in the Stock Trading Firms. Among 2 Analysts, Bottom line EPS Estimate for the current quarter is $-0.09 while the top line estimate is $-0.08 , a key information to consider for Day Trading and investing in stocks. The EPS growth rate is projected at 29.17%.

Amarin Corporation PLC reported better than expected with a surprise EPS of 23.08% or $0.03 during its most recent quarterly earnings. The Actual EPS was $-0.1 compared to the Estimated EPS of $-0.13. Dublin based Amarin Corporation PLC Last reported the Quarter results on Dec 31, 2016 and the Next earnings date is scheduled to be released on Feb 23, 2017.

In the last quarter, Amarin Corporation PLC reported Annual Earnings of $-0.1. Based on the filings, last years Annual Earnings was, $-0.64. In the last Quarter, AMRN reported a surprise Earnings per Share of 23.08% . The consensus estimate for current quarter is $-0.09 and for the current fiscal year, the estimate is $-0.36. For the Next fiscal year, the estimate is $-0.28 based on the consensus.

Amarin Corporation plc (NASDAQ:AMRN) : On Tuesday heightened volatility was witnessed in Amarin Corporation plc (NASDAQ:AMRN) which led to swings in the share price. The stock opened for trading at $2.86 and hit $2.98 on the upside , eventually ending the session at $2.97, with a gain of 3.48% or 0.1 points. The heightened volatility saw the trading volume jump to 1,416,864 shares. The 52-week high of the share price is $3.65 and the company has a market cap of $802 million. The 52-week low of the share price is at $1.24 .

Amarin Corporation plc is a global pharmaceutical group which develops innovative pharmaceutical products across a range of therapeutic areas utilizing its proprietary advanced oral and transdermal drug delivery technologies.


Share this post

Leave a Reply